Robert Matthew Lawlor, LICSW, LADC in Maplewood, MN - Social Worker

Robert Matthew Lawlor, LICSW, LADC is a Social Worker - Clinical based in Maplewood, Minnesota. Robert Matthew Lawlor is licensed to practice in Minnesota (license number 16420) and his current practice location is 1701 Cope Ave E, Suite A, Maplewood, Minnesota. He can be reached at his office (for appointments etc.) via phone at (651) 442-4177.

NPI number for Robert Matthew Lawlor is 1134414774 and his current mailing address is 1701 Cope Ave E, Suite A, Maplewood, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1134414774.

Contact Information

	Robert Matthew Lawlor, LICSW, LADC
	1701 Cope Ave E, Suite A, Maplewood, MN 55109-2641
	(651) 442-4177
	Not Available

Healthcare Provider's Profile

Full Name	Robert Matthew Lawlor
Gender	Male
Speciality	Social Worker - Clinical
Location	1701 Cope Ave E, Maplewood, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1134414774
Provider Enumeration Date: 06/11/2011
Last Update Date: 06/11/2011

Medical Identifiers

Medical identifiers for Robert Matthew Lawlor such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1134414774	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	301924 (Minnesota)	Secondary
1041C0700X	Social Worker - Clinical	16420 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert Matthew Lawlor is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert Matthew Lawlor, LICSW, LADC 1701 Cope Ave E, Suite A, Maplewood, MN 55109-2641 Ph: (651) 442-4177	Robert Matthew Lawlor, LICSW, LADC 1701 Cope Ave E, Suite A, Maplewood, MN 55109-2641 Ph: (651) 442-4177

News Archive

Researchers discover fundamental biology of calcium waves in relation to heart arrhythmias

Researchers have discovered the fundamental biology of calcium waves in relation to heart arrhythmias. The findings published this month in the January 19 edition of Nature Medicine outlines the discovery of this fundamental physiological process that researchers hope will one day help design molecularly tailored medications that correct the pathophysiology.

CMS outlines two different ways to revise Medicare payment system for skilled nursing care

In conjunction with a hearing today before the U.S. House Committee on Education and the Workforce in which Health and Human Services Secretary Kathleen Sebelius testified about the "Policies and Priorities of the U.S. Department of Health and Human Services," the Alliance for Quality Nursing Home Care underscored the importance of provider - Department collaboration in recalibrating the recently implemented Medicare payment system for skilled nursing facility care.

Diabetes medication could potentially help treat symptoms of Fragile X syndrome

Metformin, the most widely used drug to treat type 2 diabetes, could potentially be used to treat symptoms of Fragile X syndrome, an inherited form of intellectual disability and a cause of some forms of autism.

Discovery of new virus could pave way for stopping mosquito-borne disease outbreaks

Australian scientists have discovered a new virus carried by one of the country's most common pest mosquitoes. The new virus - known as Parramatta River virus - infects only mosquitoes and doesn't pose any direct health risks to people, according to University of Queensland (UQ) and University of Sydney researchers.

Century old drug clofazimine shows potential for multiple sclerosis

A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.

Robert Matthew Lawlor, LICSW, LADC - Counselor in Maplewood, MN